In addition, treatments of rP-sel-Fc markedly improved the coagulant parameters, including suppressed TF+-MPs levels and prolonged plasma clotting time and thrombocytopenia in venom-challenged mice (1 mg/kg, a sublethal dose; Fig. 3D–F). Here, TF is linked to Thrombocytopenia.